切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2023, Vol. 12 ›› Issue (03) : 190 -195. doi: 10.3877/cma.j.issn.2095-3224.2023.03.003

侧方淋巴结清扫专栏

直肠癌侧方淋巴结清扫的关键问题探讨
李绍堂()   
  1. 325000 温州医科大学附属第一医院国家临床重点专科(普通外科),温州医科大学附属第一医院结直肠肛门外科
  • 收稿日期:2022-08-08 出版日期:2023-06-25
  • 通信作者: 李绍堂
  • 基金资助:
    浙江省自然科学基金华东医药企业创新发展联合基金资助项目(LHDMY22H160002)

The discussion about key issues of lateral lymph nodes dissection for rectal cancer

Shaotang Li()   

  1. Department of Colorectal and Anal Surgery, the First Affiliated Hospital of Wenzhou Medical University,National Key Clinical Specialty (General Surgery), the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
  • Received:2022-08-08 Published:2023-06-25
  • Corresponding author: Shaotang Li
引用本文:

李绍堂. 直肠癌侧方淋巴结清扫的关键问题探讨[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 190-195.

Shaotang Li. The discussion about key issues of lateral lymph nodes dissection for rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(03): 190-195.

近年来,由于手术技术的提高,我国开展直肠癌侧方淋巴结清扫(LLND)的单位也越来越多。然而,在侧方淋巴结转移的诊断标准、手术指征、患者的获益情况等方面还存在较大争议。本文就LLND的历史研究进行回顾,并围绕其分期争议、预防性行LLND的可行性、LLND与新辅助放化疗(nCRT)的关系,最佳手术适应证等关键问题进行综述,为后续研究提供参考。

Recently, due to the improvement of surgical techniques, there are more and more units in China that carry out lateral lymph nodes dissection (LLND) for rectal cancers. However, there are still some controversies over the diagnostic criteria for lateral lymph nodes metastases, indications for surgery, whether the patient benefits and other aspects. This article reviewed the historical studies of lateral lymph nodes dissection, and also reviewed key issues such as the feasibility of prophylactic lateral lymph nodes dissection, the relationship between LLND and neoadjuvant chemoradiotherapy(nCRT), and the optimal surgical indications, provided a reference for follow-up studies.

[1]
Gerota D. Die lymphgefasse des rectums und des anus [J]. Arch Anat Physiol, 1895, 7(240): 56.
[2]
Bell S, Sasaki J, Sinclair G, et al. Understanding the anatomy of lymphatic drainage and the use of blue-dye mapping to determine the extent of lymphadenectomy in rectal cancer surgery: unresolved issues [J]. Colorec Dis, 2009, 11(5): 443-449.
[3]
Miles WE. The spread of cancer of the rectum [J]. The Lancet, 1925, 205(5310): 1218-1219.
[4]
Senba Y. An anatomical study of lymphatic system of the rectum (in Japanese). [J]. J Hukuoka Med Coll, 1927, 20: 1213-1268.
[5]
Kuru M. Cancer of the rectum (in Japanese) [J]. J Jpn Surg Soc, 1940, 41: 832-877.
[6]
Coller FA, Kay EB, Macintyre RS. Regional lymphatic metastases of carcinoma of the colon [J]. Ann Surg, 1941, 114(1): 56-67.
[7]
Dukes CE. The surgical pathology of rectal cancer: president's address [J]. Proceedings of the Royal Society of Medicine, 1944, 37(4): 131-144.
[8]
Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis [J]. Am J Surg, 1951, 81(1): 111-120.
[9]
Waugh JM, Kirklin JW. The importance of the level of the lesion in the prognosis and treatment of carcinoma of the rectum and low sigmoid colon [J]. Ann Surg, 1949, 129(1): 22-33.
[10]
Stearns MW, Jr., Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum [J]. Dis Colon Rectum, 1959, 2(2): 169-172.
[11]
Weiser MR. AJCC 8th edition: colorectal cancer [J]. Ann Surg Oncol, 2018, 25(6): 1454-1455.
[12]
Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? [J]. Ann Surg, 2012, 255(6): 1129-1134.
[13]
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer [J]. N Engl J Med, 2001, 345(9): 638-646.
[14]
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer [J]. N Engl J Med, 2004, 351(17): 1731-1740.
[15]
van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial[J]. Lancet Oncol, 2011, 12(6): 575-582.
[16]
Kusters M, Uehara K, Velde C, et al. Is there any reason to still consider lateral lymph node dissection in rectal cancer? rationale and technique [J]. Clin Colon Rectal Surg, 2017, 30(5): 346-356.
[17]
Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis [J]. Lancet Oncol, 2009, 10(11): 1053-1062.
[18]
Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial [J]. Ann Surg, 2017, 266(2): 201-207.
[19]
Fujita S, Mizusawa J, Kanemitsu Y, et al. A randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage Ⅱ, Ⅲ lower rectal cancer: Primary endpoint analysis of Japan Clinical Oncology Group study JCOG0212 [J]. J Clin Oncol, 2016, 34(15_suppl): 3508-3508.
[20]
中国医师协会内镜医师分会腹腔镜外科专业委员会, 中国医师协会结直肠肿瘤专业委员会腹腔镜专业委员会, 中华医学会外科学分会结直肠外科学组. 中国直肠癌侧方淋巴结转移诊疗专家共识(2019版) [J]. 中华胃肠外科杂志, 2019, 22(10): 901-912.
[21]
MacFarlane J, Ryall R, Heald R. Mesorectal excision for rectal cancer [J]. The Lancet, 1993, 341(8843): 457-460.
[22]
Yamaguchi T, Konishi T, Kinugasa Y, et al. Laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer: a subgroup analysis of a large multicenter cohort study in Japan [J]. Dis Colon Rectum, 2017, 60(9): 954-964.
[23]
Fujita S, Akasu T, Mizusawa J, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial [J]. Lancet Oncol, 2012, 13(6): 616-621.
[24]
Birgisson H, Påhlman L, Gunnarsson U, et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer [J]. J Clin Oncol, 2005, 23(25): 6126-6131.
[25]
Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence [J]. Ann Surg, 2009, 249(2): 229-235.
[26]
Kim TH, Jeong SY, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection [J]. Ann Surg Oncol, 2008, 15(3): 729-737.
[27]
Kim MJ, Kim TH, Kim DY, et al. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? [J]. J Surg Oncol, 2015, 111(4): 459-464.
[28]
Malakorn S, Yang Y, Bednarski BK, et al. Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation? [J]. Dis Colon Rectum, 2019, 62(10): 1158-1166.
[29]
Wei M, Wu Q, Fan C, et al. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial [J]. Trials, 2016, 17(1): 561.
[30]
Hoshino N, Murakami K, Hida K, et al. Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis [J]. Inter J Clin Oncol, 2019, 24(1): 46-52.
[31]
Park BK, Lee SJ, Hur BY, et al. Feasibility of selective lateral node dissection based on magnetic resonance imaging in rectal cancer after preoperative chemoradiotherapy [J]. J Surg Res, 2018, 232: 227-233.
[32]
Ogawa S, Hida J, Ike H, et al. Selection of lymph node-positive cases based on perirectal and lateral pelvic lymph nodes using magnetic resonance imaging: study of the Japanese society for cancer of the colon and rectum [J]. Ann Surg Oncol, 2016, 23(4): 1187-1194.
[33]
Lee D, Matsuda T, Yamashita K, et al. Significance of lateral pelvic lymph node size in predicting metastasis and prognosis in rectal cancer[J]. Anticancer Res, 2019, 39(2): 993-998.
[34]
Kim MJ, Hur BY, Lee ES, et al. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings [J]. PloS One, 2018, 13(4): e0195815.
[35]
Ishihara S, Kawai K, Tanaka T, et al. Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy [J]. ANZ Journal of Surgery, 2018, 88(12): 1306-1310.
[36]
Akiyoshi T, Matsueda K, Hiratsuka M, et al. Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer [J]. Ann Surg Oncol, 2015, 22(3): 614-620.
[37]
Yamaoka Y, Kinugasa Y, Shiomi A, et al. Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer [J]. Inter J Colorec Dis, 2017, 32(11): 1631-1637.
[38]
Ogura A, Konishi T, Beets GL, et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy[J]. JAMA Surgery, 2019, 154(9): e192172.
[39]
Hojo K, Vernava AM, 3rd, Sugihara K, et al. Preservation of urine voiding and sexual function after rectal cancer surgery[J]. Dis Colon Rectum, 1991, 34(7): 532-539.
[40]
Moriya Y, Sugihara K, Akasu T, et al. Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer[J]. European Journal of Cancer (Oxford, England: 1990), 1995, 31a(7-8): 1229-1232.
[41]
Moriya Y, Sugihara K, Akasu T, et al. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence [J]. Dis Colon Rectum, 1995, 38(11): 1162-1168.
[42]
Sugihara K, Moriya Y, Akasu T, et al. Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome [J]. Cancer, 1996, 78(9): 1871-1880.
[43]
Mori T, Takahashi K, Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection [J]. Langenbecks Arch Surg, 1998, 383(6): 409-415.
[1] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[2] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[3] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[4] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[5] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[6] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[7] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[8] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[9] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[10] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[11] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[12] 马慧颖, 凡新苓, 覃仕瑞, 陈佳赟, 曹莹, 徐源, 金晶, 唐源. 磁共振加速器治疗局部晚期直肠癌的初步经验[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 519-523.
[13] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[14] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[15] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
阅读次数
全文


摘要